B

Braidwell Portfolio holdings

AUM $3.37B
1-Year Est. Return 0.13%
This Quarter Est. Return
1 Year Est. Return
+0.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.37B
AUM Growth
+$446M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
80
New
Increased
Reduced
Closed

Top Buys

1
+$86.7M
2
+$50.8M
3
+$44.7M
4
CVS icon
CVS Health
CVS
+$33.1M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$32.9M

Top Sells

1
+$87.3M
2
+$46.8M
3
+$43.6M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$39.3M
5
KRYS icon
Krystal Biotech
KRYS
+$36.6M

Sector Composition

1 Healthcare 73.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EHC icon
51
Encompass Health
EHC
$11.5B
$14.4M 0.43%
+113,335
VERA icon
52
Vera Therapeutics
VERA
$2.11B
$13.7M 0.41%
+472,739
NEO icon
53
NeoGenomics
NEO
$1.56B
$13.7M 0.41%
+1,771,146
TECX
54
Tectonic Therapeutic
TECX
$383M
$11.6M 0.34%
+736,867
REPL icon
55
Replimune Group
REPL
$762M
$11.5M 0.34%
2,750,092
+2,327,205
ADPT icon
56
Adaptive Biotechnologies
ADPT
$2.88B
$11M 0.33%
736,014
-3,127,093
ZURA icon
57
Zura Bio
ZURA
$242M
$10.7M 0.32%
2,472,806
SION
58
Sionna Therapeutics
SION
$1.74B
$9.24M 0.27%
314,013
-767,842
AMLX icon
59
Amylyx Pharmaceuticals
AMLX
$1.56B
$8.33M 0.25%
+612,841
RPRX icon
60
Royalty Pharma
RPRX
$17B
$6.42M 0.19%
+182,068
FULC icon
61
Fulcrum Therapeutics
FULC
$534M
$2.02M 0.06%
+219,488
SRZN icon
62
Surrozen
SRZN
$138M
$1.8M 0.05%
140,000
HTFL
63
Heartflow Inc
HTFL
$2.57B
$1.68M 0.05%
+50,000
LUNG icon
64
Pulmonx
LUNG
$72.6M
$1.22M 0.04%
752,541
APLS icon
65
Apellis Pharmaceuticals
APLS
$2.68B
– –
-1,121,034
CELC icon
66
Celcuity
CELC
$4.56B
– –
-884,306
GH icon
67
Guardant Health
GH
$13.7B
– –
-837,800
CBIO
68
Crescent Biopharma
CBIO
$239M
– –
-261,504
MDGL icon
69
Madrigal Pharmaceuticals
MDGL
$13.2B
– –
-60,781
UNH icon
70
UnitedHealth
UNH
$293B
– –
-49,400
1 2
3